{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:30:56Z","timestamp":1794508256045,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["ID-JIP\/Res\/Intramural\/Phs1\/2018-19"],"award-info":[{"award-number":["ID-JIP\/Res\/Intramural\/Phs1\/2018-19"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.eplepsyres.2021.106786","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:46:16Z","timestamp":1633740376000},"page":"106786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["CYP2C19 & UGT1A6 genetic polymorphisms and the impact on Valproic acid-induced weight gain in people with epilepsy: Prospective genetic association study"],"prefix":"10.1016","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7598-8875","authenticated-orcid":false,"given":"Balachandran","family":"Mani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-2631","authenticated-orcid":false,"given":"Pradeep Pankajakshan","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Sekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadishkumar","family":"Kamalanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9866-2894","authenticated-orcid":false,"given":"Sunil K.","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramasamy","family":"Kesavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2021.106786_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/ane.12313","article-title":"Insulin resistance in patients on valproic acid: relation to adiponectin","volume":"131","author":"Aly","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12966-015-0196-2","article-title":"Reliability and validity of a new physical activity questionnaire for India","volume":"12","author":"Anjana","year":"2015","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/dmd.108.022426","article-title":"Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10","volume":"37","author":"Argikar","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2013.08.016","article-title":"Metabolic and endocrine effects of valproic acid chronic treatment","volume":"107","author":"Belcastro","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/08830738030180021701","article-title":"Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial","volume":"18","author":"Biton","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0030","doi-asserted-by":"crossref","first-page":"e14822","DOI":"10.1371\/journal.pone.0014822","article-title":"Dietary intake and rural-urban migration in India: a cross-sectional study","volume":"6","author":"Bowen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0035","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/dmd.104.003327","article-title":"Characterization of testosterone 11 beta-hydroxylation catalyzed by human liver microsomal cytochromes P450","volume":"33","author":"Choi","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0040","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00228-012-1277-7","article-title":"Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients","volume":"68","author":"Chu","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0317167100021879","article-title":"Weight gain in epileptic patients during treatment with valproic acid: a retrospective study","volume":"24","author":"Corman","year":"1997","journal-title":"Can J. Neurol. Sci. Le J. Can. des Sci. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0887-8994(00)00133-8","article-title":"Weight gain associated with valproate in childhood","volume":"22","author":"Demir","year":"2000","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mgene.2016.06.004","article-title":"Rapid and ultra-rapid metabolizers with CYP2C19*17 polymorphism do not respond to standard therapy with proton pump inhibitors","volume":"9","author":"Deshpande","year":"2016","journal-title":"Meta Gene"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0404.1984.tb00804.x","article-title":"Weight gain during treatment with valproate","volume":"70","author":"Dinesen","year":"1984","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1059-1311(97)80065-9","article-title":"Weight gain with valproate or carbamazepine--a reappraisal","volume":"6","author":"Easter","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bmj.283.6291.577","article-title":"Effects of sodium valproate in 100 children with special reference to weight","volume":"283","author":"Egger","year":"1981","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0075","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2133\/dmpk.DMPK-11-NT-144","article-title":"Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy","volume":"27","author":"Guo","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0080","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"39","author":"Isoj\u00e4rvi","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-4165(90)90079-C","article-title":"The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase","volume":"1034","author":"Ito","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0028-3886.152631","article-title":"Prevalence of UGT1A6 polymorphisms in children with epilepsy on valproate monotherapy","volume":"63","author":"Jain","year":"2015","journal-title":"Neurol. India"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1472-8206.2004.00307.x","article-title":"CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population","volume":"19","author":"Jose","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.seizure.2012.05.001","article-title":"Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy","volume":"21","author":"Kanemura","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13312-015-0566-5","article-title":"Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children","volume":"52","author":"Khadilkar","year":"2015","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1067\/mcp.2000.109365","article-title":"CYP2C19 genetic mutations in North Indians","volume":"68","author":"Lamba","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0115","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00228-018-2440-6","article-title":"Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model","volume":"74","author":"Mei","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40291-013-0041-8","article-title":"The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach","volume":"17","author":"Munisamy","year":"2013","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/ane.12473","article-title":"Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain","volume":"133","author":"Noai","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylv\u00e4nen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0135","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/en.2005-1030","article-title":"Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid","volume":"147","author":"Qiao","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0140","series-title":"Atlas of the Languages and Ethnic Communities of South Asia","author":"Roland","year":"1993"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0145","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1528-1167.2007.01100.x","article-title":"Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study","volume":"48","author":"S","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2133\/dmpk.20.85","article-title":"Genetic polymorphisms of UGT1A6 in a Japanese population","volume":"20","author":"Saeki","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.clineuro.2010.01.002","article-title":"The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients","volume":"112","author":"Tan","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0238201","article-title":"Safety range of free valproic acid serum concentration in adult patients","volume":"15","author":"Tseng","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0165","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.53.1.230","article-title":"Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid","volume":"53","author":"Verrotti","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eplepsyres.2007.11.005","article-title":"Increased oxidative stress in epileptic children treated with valproic acid","volume":"78","author":"Verrotti","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0175","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/j.1467-789X.2010.00800.x","article-title":"Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications","volume":"12","author":"Verrotti","year":"2011","journal-title":"Obes. Rev."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0180","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2217\/pgs.09.21","article-title":"Systematic screening for polymorphisms within the UGT1A6 gene in three Chinese populations and function prediction through structural modeling","volume":"10","author":"Xing","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/abbi.1997.0302","article-title":"Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes","volume":"346","author":"Yamazaki","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0190","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pharmthera.2009.12.002","article-title":"Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases","volume":"125","author":"Zordoky","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2021.106786_bib0195","doi-asserted-by":"crossref","first-page":"639","DOI":"10.31083\/ph.2012.1735","article-title":"Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in han, uighur, Hui and mongolian chinese populations","volume":"67","author":"Zuo","year":"2012","journal-title":"Pharmazie"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121002394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121002394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:37:03Z","timestamp":1778701023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121121002394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":39,"alternative-id":["S0920121121002394"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106786","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP2C19 & UGT1A6 genetic polymorphisms and the impact on Valproic acid-induced weight gain in people with epilepsy: Prospective genetic association study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106786"}}